TrialMolecular oncology2021

Blood-based detection of lung cancer using cysteine-rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study.

Lucija Ačkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.